Bigbear Pharmaceutical·Medication Guide

• FDA Approves Xalkori (crizotinib) for ALK-Positive Inflammatory Myofibroblastic Tumors

  FDA Approval AnnouncementOn July 14, 2022, the U.S. Food and Drug Administration (FDA) approved crizotinib (Xalkori, Pfizer Inc.) for adult and pediat···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 223

• What should I avoid while taking tepotinib

  Follow your doctor's instructions about any restrictions on food, beverages, or activity.【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 211

• What other drugs will affect tepotinib

  Other drugs may affect tepotinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all oth···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 164

• What happens if I miss a dose of tepotinib

  Take the medicine as soon as you can, but skip the missed dose if your next dose is due within 8 hours. Do not take two doses at one time.【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 173

• What is tepotinib

  Tepotinib is used in adults to treat non-small cell lung cancer that has spread to other parts of the body (metastatic).Your doctor will make sure you···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 171

• Legitimate Purchase Methods for Genuine Tepotinib

  For patients requiring this medication, ensuring the purchase of genuine tepotinib is critically important. Currently, multiple formal channels are av···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 183

• Latest 2026 Price of Tepotinib Released Online

  Tepotinib is the world’s first highly selective MET inhibitor, playing a crucial role in treating non‑small cell lung cancer (NSCLC) with MET exon 14 ···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 168

• Targeting METex14 Skipping Mutation: New NSCLC Drug TEPMETKO (Tepotinib)

  Drug OverviewTEPMETKO, also known as tepotinib, is an oral kinase inhibitor approved for the treatment of patients with metastatic non‑small cell lung···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 171

• Drug Introduction of Tepotinib

  Tepotinib is a tyrosine kinase inhibitor targeting MET exon 14 skipping mutations, mainly used for the treatment of patients with advanced or metastat···【Read More】

  Update: 2026-03-09Source: Haiou HealthViews: 163

• What other drugs may affect osimertinib?

  Osimertinib may cause a severe heart condition. Your risk may be increased if you also take certain other medications used to treat infections, asthma···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 184

• What should I avoid while taking osimertinib?

  While taking osimertinib, follow all dietary, beverage, and activity restrictions provided by your doctor.【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 180

• What if I overdose?

  In case of an overdose, get emergency medical help immediately or call the Poison Help line.【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 182

• What if I miss a dose?

  If you forget to take a dose, simply skip the missed one and take your next dose at your usual scheduled time. Do not take two doses at once to make u···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 177

• Detailed Product Information for Osimertinib (Tagrisso), a Targeted Therapy

  Osimertinib is indicated for the treatment of various types of non-small cell lung cancer (NSCLC). Before initiating treatment, an FDA-approved diagno···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 178

• Osimertinib (Targeted Therapy) Instructions for Use

  Since its FDA approval in the United States in 2015, Osimertinib has been widely used and recognized globally. In China, Osimertinib is marketed and i···【Read More】

  Update: 2026-03-06Source: Haiou HealthViews: 182